Time: October 27 to October 31, 2008.
Location: Fudan University Crowne Plaza, Shanghai, China.
Agenda for the 14th International p53 Workshop
(
)
(Welcome
欢迎)
p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53p53
Sunday, 10/26/08
Arrival, Check-in at Hotels, and Free Exploration of Shanghai
********************************************************************
Monday 10/27/08
7:00-9:00AM
Breakfast at
Attendees’ Own Hotels
Day time
Free Exploration of Shanghai and Dining on Your Own
2:00PM
Registration Starts at 2pm at Crowne Plaza Hotel at
Fudan, Shanghai
7:30-9:30PM
Session 1
Crowne Plaza Second Floor Meeting Room
Keynote Talks
7:30-7:45PM
Welcome Address from Fudan University
7:45-8:00PM
Logistics by the Organizers (Wei
Gu and Hua Lu)
8:00-8:45PM
A. J. Levine Single Nucleotide Polymorphisms in the p53 Pathway (S1)
8:45-9:30PM
D. P. Lane Activating p53 Pathway from Fish to Man (S2)
9:30-Midnight
Social Time
********************************************************************
Tuesday 10/28/08
7:00-8:30AM Breakfast at Attendees’ Own Hotels
8:30-10:05AM Session 2
Crowne Plaza Second Floor Meeting Room
Transcriptional Regulation of p53
(Chairs: Robert Roeder and Carol Prives)
8:30-8:55AM
R. Roeder Function of Diverse Cofactors in Transcriptional
Activation
by p53 (S3)
8:55-9:20AM C. Prives Regulation of p53 by MDM2 and MDMX (S4)
9:20-9:45AM C. Harris Telomeres “Coming up Short”: p53-dependent Senescence
(S5)
9:45-10:05AM Y. Taya Novel Functions of p53 at Nucleus and Near Plasma
Membrane (S6)
10:05-10:20AM Coffee Break
10:20-12:00AM
Session 3
Crowne Plaza Second Floor Meeting Room
p53 Structure and Function I
(Chairs: Alan Fersht and Michael Resnick)
10:20-10:45AM A. Fersht Target Mutant Rescue (S7)
10:45-11:10AM M. Resnick The Expanding p53 Universe (S8)
11:10-11:30AM G.P. Zambetti Regulating Nuclear Import by p53 through E124/PIG8
(S9)
11:30-11:45AM L. Mayo The PTEN/p53/MASPIN Network to Suppress Angiogenesis
(S10)
11:45-12:00PM Z. Xiao IGF-1 Induces Premature Cellular Senescence via p53
Activation (S11)
12:00-2:00PM Lunch and Poster Session I at Crowne Plaza
2:00-3:40PM
Session 4
Crowne Plaza Second Floor Meeting Room
p53 Structure and
Function II
(Chairs: Wafik El-Deiry and Xinbin Chen)
2:00-2:25PM W. El-Deiry Targeting Mutant p53 in Cancer Stem Cells (S12)
2:25-2:45PM
X. Chen
Identification of ID2 as a Mutant p53-specifc Target Gene
and Establishment of a Dog Model for the p53 Pathway
(S13)
2:45-3:05PM
J. Manfredi p53 Regulates Mitotic Entry and Progression via Effects
on Transcription and Protein Stability of Specific Targets
(S14)
3:05-3:25PM
S. Lee Identification of p53 Activators with Potent Anti-tumor
Activities
(S15)
3:25-3:40PM W. Hu p53 Regulates Maternal Reproduction through Leukemia
Inhibitory Factor (S16)
3:40-3:55PM Coffee Break
3:55-6:05PM
Session 5
Crowne Plaza Second Floor Meeting Room
p53 Regulation: Mdm2, Mdmx
and Others
(Chairs: Moshe
Oren and Hua Lu)
3:55-4:20PM M. Oren Inhibitory Interactions between MDM2 and Ribosomal
Protein L26 Regulate p53 Synthesis and Stability (S17)
4:20-4:40PM H. Lu Activation of p53 via Suppression of MDM2 and MDMX (S18)
4:40-5:00PM A. Jochemsen Functions and Regulation of MDMX (S19)
5:00-5:20PM J. Chen ATM Inhibition of MDM2 Oligomerization and p53 Poly-
ubiquitylation Is Essential for p53 Activation after DNA Damge (S20)
5:20-5:35PM Z.M. Yuan Investigation of the MDM2 Acidic Domain for Its Role in
p53 Ubiquitination (S21)
5:35-5:50PM S.C. Lin Axin Is Critical Determinant for Decision between Death and
Life upon DNA Damage (S22)
5:50-6:05PM W.G. Zhu p53 Interacts with NUMB to Inhibit Proliferation of Colon
Cancer Cells (S23)
6:05-7:30PM Dinner at Crowne Plaza First Floor Cafeteria
7:30-9:45PM
Session 6
Crowne Plaza Second Floor Meeting Room
p53 Regulation: Protein Modifications
(Chairs: Wei Gu and David Meek)
7:30-7:55PM W. Gu p53 Regulation via Acetylation and Ubiquitylation (S24)
7:55-8:15PM D. Meek p53-mediated Down-regulation of PLK1 Expression as Part
of the G2/M Checkpoint to DNA Damage (S25)
8:15-8:35PM S. Grossman Sibling Rivalry: Differential Regulation of p53 by p300
and CBP (S26)
8:35-8:55PM E. Appella Synthesis and Activity of Selective Inhibitors of WIP1, a
Phosphatase that Controls p53 Pathways (S27)
8:55-9:15PM
S. Shieh
Stress-induced Signaling Pathways Connecting
TTK/hMPS1, ChK2 and p53 (S28)
9:15-9:30PM
N. Barlev
Transcrtiptional Regulation of micro-RNAs by p53 Defines
the Outcome of Genotoxic Stress (S29)
9:30-9:45PM Z.K. Lou DBC1 Negatively Regulates Sirt1 and Potentiates p53
Activity (S30)
********************************************************************
Wednesday 10/29/08
7:00-8:30AM Breakfast at Attendees’ Own Hotels
8:30-10:15AM Session 7
Crowne Plaza Second Floor Meeting Room
Regulation of Cell Survival, Death
and Others
(Chairs: Douglas Green and Yanping Zhang)
8:30-8:55AM D. Green p53, PUMA, and Bcl2 Family Interactions: Covert Direct
Activator BH3-only Protein Function Is Revealed by PUMA-mediated
De-repression (S31)
8:55-9:20AM
Y.P. Zhang
Function and Mechanism of ARF in the Mitochondria
(S32)
9:20-9:40AM M. Murphy The ARF Tumor Suppressor Confers Survival in
Response to Metabolic Stress (S33)
9:40-10:00AM Z. Dong Interaction of p53 and Histone H3 via Different Protein
Kinases (S34)
10:00-10:15AM
L.
Zhang
PUMA as an Essntial Mediator in p53-dependent and
Independent Apoptosis (S35)
10:15-10:30AM Coffee Break
10:30-12:05PM
Session 8
Crowne Plaza Second Floor Meeting Room
In Vivo Function
(I)
(Chairs: Scott Lowe and Xin Lu)
10:30-10:55AM S. Lowe p53-mediated Senescence of Activated Stellate Cells Limits
Liver Fibrosis (S36)
10:55-11:20AM G. I. Evan p53 and Tumor Suppression--the How, the When and the
Why (S37)
11:20-11:45AM X. Lu p53: a Heavily Dictated “Dictator” of Life and Death (S38)
11:45-12:05PM T. Tlsty Telomere Malfunction Acts through Paracrine Signaling to
Condition Adjacent Cells to either Promote or Suppress Malignant
Phenotypes (S39)
12:05-2:00PM Lunch and Poster Session II at Crowne Plaza
2:00-4:25PM Session 9
Crowne Plaza Second Floor Meeting Room
In
Vivo Function (II)
(Chairs: Gigi Lozano and Geoff Wahl)
2:00-2:25PM G. Lozano Mutant p53 Gain-of-function activities (S40)
2:25-2:50PM T. Mak The Role of TAp73 and DNp73 in Tumor Development (S41)
2:50-3:15PM G. Wahl Unleasing the Guardian: Developing More Effective p53
Activating Therapies by Targeting MDM2 and MDMX, Its Two
Negative Regulators (S42)
3:15-3:35PM Y. Xu Genetic Analysis of p53 in Aging (S43)
3:35-3:55PM L. Attardi Using Transactivation Domain Mutant Knock-in Mice to
Define p53’s Mechanism of Action (S44)
3:55-4:10PM
S. Chang
Telomere Dysfunction Suppresses Tumorigenesis in Vivo
by Initiating p53-dependent Cellular Senescence (S45)
4:10-4:25PM U Rodeck Distinct and Interdependent Functional Roles of N-
Terminal p53 Variants in Zebrafish Development (S46)
4:30PM Bus to a Restaurant
5:30-7:00PM
Dinner
7:00-8:00PM
Bus to the Huang Pu River
Port
8:00-9:00PM Boat Tour on Huang Pu River in the Center of Shanghai City.
9:00-10:00PM Return to Hotels
********************************************************************
Thursday 10/30/08
7:00-8:30AM
Breakfast at
Attendees’ Own Hotels
8:30-10:10AM
Session 10
Crowne Plaza Second Floor Meeting Room
p53 Targets
(Chairs: Varda Rotter and Karen Vousden)
8:30-8:55AM K. Vousden A Role for the p53 Tumor Suppressor Protein in
Metabolism (S47)
8:55-9:20AM V. Rotter Identification and Characterization of p53-associated “Gene
Signatures” Involved in Cellular Transformation (S48)
9:20-9:40 AM S. Benchimol LPIN1, a Novel p53-regulated Gene Induced in
Response to Metabolic Stress and DNA Damage (S49)
9:40-9:55 AM S. Berberich YPEL3, a Novel p53 Regulated Gene with
Growth Suppressive Activity (S50)
9:55-10:10AM A. Budanov The p53-regulated Sestrin Gene Products Inhibit mTOR
Signaling (S51)
10:10-10:25AM Coffee Break
10:25-12:00PM
Session 11
Crowne Plaza Second Floor Meeting Room
p53 in the Clinic and Models
(Chair: Lin Wu)
10:25-10:50AM L. Wu Detection of p53 Mutations in Cancer by the AmpliChip p53
Test, a Microarray-based Resequencing Assay (S52)
10:50-11:10AM F. Bunz New Isogenic Models to Discover p53-dependent
Therapeutics (S53)
11:10-11:30AM J.C. Bourdon Human p53 Isoforms and Cancer (S54)
11:30-11:45AM K.H. Young Structural Profiles of TP53 Gene Mutations Predict
Clinical Outcomes Lymphoma: An International Collaborative Study
(S55)
11:45-12:00AM Steve Yu A New Resource to Provide a Full Spectrum of Human
p53 Point Mutations in
Humanized Mouse Models (S56)
12:00-2:00PM Lunch and Poster Session III at Crowne Plaza
2:00-4:50PM
Session 12
p63, p73 and
Others
(Chairs: Frank McKeon and Ute Moll)
2:00-2:25PM F. McKeon p63: Dual Roles in Female Germline Superiority and
Epithelial “Stemness” (S57)
2:25-2:50PM U. Moll Tumor Suppressor Properties of p73 in T- and B-cell
Lymphomas (S58)
2:50-3:10PM G. Melino p63, miRNA, “Stemness” and Skin (S59)
3:10-3:25PM E. Flores TAp63 is a Key Regulator of Wound Repair,
Stem Cell Maintenance, and Tumor Suppression (S60)
3:25-3:40PM Coffee Break
3:40-3:55PM Y. Haupt Regulation of the p53 Activator PML (S61)
3:55-4:10PM Y. Yin A Network of p53 and E2F-1 in Controlling Cellular Response
to Oxidative Stress (S62)
4:10-4:30PM F.C. He PACT is a Negative Regulator of p53 and Essential for Cell
Growth and Embryonic Development (S63)
4:30-4:50PM A. Braithwaite The Polyproline Domain of p53 Is Required for
Apoptosis and for Prevention Function of B Cell Lymphoma (S64)
5:00-6:00PM Bus to Banquet
6:30-12:00AM Banquet with Live Music
********************************************************************
Friday 10/31/08
7:00-8:30AM Breakfast at Attendees’ Own Hotels
8:30-11:05PM
Session 13
Crowne Plaza Second Floor Meeting Room
Cancer
Therapy
(Chairs: Lubo Vassilev
and Shaomeng Wang)
8:30-8:55AM
L. Vassilev
Nultins: p53 Research Tools and Potential Therapeutics
(S65)
8:55-9:15AM S.M. Wang Small-molecule Approach to Reactivate p53 by Blocking
the MDM2-p53 Interaction as a New Cancer Therapeutic Approach:
Progress and Challenges (S66)
9:15-9:35AM Y. Sun A Class of Small Molecules that Promote p53 Degradation
(S67)
9:35-9:50AM G. Selivanova Molecular Mechanisms of Preferential Induction of
Apoptosis by Pharmacological Reactivation of p53 (S68)
9:50-10:05AM
Coffee Break
10:05-10:20AM K.G. Wiman Mutant p53 Targeting by Prima-1:
From Drug Discovery to Clinical Trials (S69)
10:20-10:35AM C. Maki Transient Nutlin-3a Treatment Promotes Endoreduplication
and the Generation of Therapy-resistant Tetraploid Cells (S70)
10:35-10:50AM M. Laiho Identification of Novel p53 Pathway Activating Small
Molecule Compounds (S71)
10:50-11:05Am
S. Lain
Discovery of Small Molecule Sirtuin Inhibitors Through a p53
Activation Assay (S72)
Closing Session
11:05-11:45AM
Special Lecture by
A.J. Levine: 30 Years of p53 Research
11:45-12:00PM
Final Logistics: Wei Gu and Hua Lu
12:00PM
Lunch at Crowne First Floor Cafeteria
Good-bye (再见)



